Atara Biotherapeutics announces James Huang and Nachi Subramanian to join its Board of Directors

– USA, CA –  Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy developping transformative therapies for patients with cancer and autoimmune diseases, announced the appointments of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the $16 million offering that was announced on May 15, 2025.…

Talent4Boards
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.